Cargando…

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease

Parkinson’s disease (PD) is a chronic progressive neurodegenerative disease that is increasingly becoming a global threat to the health and life of the elderly worldwide. Although there are some drugs clinically available for treating PD, these treatments can only alleviate the symptoms of PD patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Gu, Zhicheng, Lin, Shuxian, Chen, Lei, Dzreyan, Valentina, Eid, Moez, Demyanenko, Svetlana, He, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140162/ https://www.ncbi.nlm.nih.gov/pubmed/35625059 http://dx.doi.org/10.3390/brainsci12050672

Ejemplares similares

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
por: Demyanenko, Svetlana, et al.
Publicado: (2021)

Sirtuins 1 and 2 in the Acute Period After Photothrombotic Stroke: Expression, Localization and Involvement in Apoptosis
por: Eid, Moez, et al.
Publicado: (2022)

E2F1 Expression and Apoptosis Initiation in Crayfish and Rat Peripheral Neurons and Glial Cells after Axonal Injury
por: Dzreyan, Valentina, et al.
Publicado: (2022)

Epigenetic Alterations Induced by Photothrombotic Stroke in the Rat Cerebral Cortex: Deacetylation of Histone h3, Upregulation of Histone Deacetylases and Histone Acetyltransferases
por: Demyanenko, Svetlana, et al.
Publicado: (2019)

Histone Methyltransferases SUV39H1 and G9a and DNA Methyltransferase DNMT1 in Penumbra Neurons and Astrocytes after Photothrombotic Stroke
por: Sharifulina, Svetlana, et al.
Publicado: (2021)

Histone deacetylase 10, a potential epigenetic target for therapy
por: Cheng, Fajuan, et al.
Publicado: (2021)

The Role of p53 Protein in the Realization of the Exogenous Heat Shock Protein 70 Anti-Apoptotic Effect during Axotomy
por: Demyanenko, Svetlana V., et al.
Publicado: (2021)

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
por: Park, Hyun-Sun, et al.
Publicado: (2021)

Patho-epigenetics: histone deacetylases as targets of pathogens and therapeutics
por: Schator, Daniel, et al.
Publicado: (2021)

Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors
por: Sharifulina, Svetlana, et al.
Publicado: (2022)

Histone deacetylases in RA: epigenetics and epiphenomena
por: Grabiec, Aleksander M, et al.
Publicado: (2010)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Targeting Histone Deacetylases: A Novel Approach in Parkinson's Disease
por: Sharma, Sorabh, et al.
Publicado: (2015)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease
por: Wang, Zi-Ying, et al.
Publicado: (2015)

Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2021)

Histone acetylation and deacetylation in ischemic stroke
por: Uzdensky, Anatoly B., et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018)

Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
por: Goutas, Dimitrios, et al.
Publicado: (2021)

Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes
por: Doke, Mayur, et al.
Publicado: (2021)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
por: Xu, Qing-Yu, et al.
Publicado: (2020)

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
por: Cang, Shundong, et al.
Publicado: (2009)

Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors
por: Chen, Shuyang, et al.
Publicado: (2011)

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer
por: Wang, Guan, et al.
Publicado: (2012)

Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives
por: Ghiboub, Mohammed, et al.
Publicado: (2021)

Targeting Huntington’s disease through histone deacetylases
por: Gray, Steven G.
Publicado: (2011)

DNA and histone deacetylases as targets for neuroblastoma treatment
por: Stiborová, Marie, et al.
Publicado: (2010)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Epigenetic modification in histone deacetylase deletion strain of Calcarisporium arbuscula leads to diverse diterpenoids
por: Bai, Jian, et al.
Publicado: (2018)

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
por: Delcuve, Geneviève P, et al.
Publicado: (2012)

Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
por: Autin, Pierre, et al.
Publicado: (2019)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023)

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
por: Jiang, Li-Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4nt7l8a8q97lt14a1f2s5lihk3